Literature DB >> 28605954

Surgical resection of pulmonary inflammatory pseudotumors: long-term outcome.

Marine Peretti1, Dana M Radu1, Karel Pfeuty2, Antoine Dujon3, Marc Riquet4, Emmanuel Martinod1.   

Abstract

Background Pulmonary inflammatory pseudotumors are rare lesions that remain problematic in several aspects, especially regarding the therapeutic strategy. The goal of this study was to evaluate long-term survival in a multicenter series of patients who required surgery for pulmonary inflammatory pseudotumors. Methods Thirty-six cases of pulmonary inflammatory pseudotumors, operated on in 3 French thoracic surgery departments between 1989 and 2015, were studied retrospectively. We recorded pre-, peri- and postoperative data for each patient, and long-term survival was analyzed. Results There were 22 men and 14 women. Mean age was 53.5 years (range 14-81 years). Three pneumonectomies, 1 bilobectomy, 19 lobectomies, 2 segmentectomies, 10 wedge resections, and 1 biopsy were performed. Complete resection was carried out in 32 (88.8%) patients. Median follow-up was 76 months. Five-year and 10-year survival rates were respectively 86.8% and 81.7% (96% and 90% for patients with R0 resection). Conclusions Long-term survival was excellent for patients with pulmonary inflammatory pseudotumors who benefited from surgery, especially when surgical resection was complete. These results confirm that surgical resection must be proposed as the first-line treatment for patients with pulmonary inflammatory pseudotumors.

Entities:  

Keywords:  Diagnosis; Lung neoplasms; Plasma cell granuloma; Pneumonectomy; differential; pulmonary

Mesh:

Year:  2017        PMID: 28605954     DOI: 10.1177/0218492317716587

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  2 in total

1.  Operated pulmonary inflammatory myofibroblastic tumors: Our experience with 17 cases.

Authors:  Cabir Yüksel; Bülent Mustafa Yenigün; Gökhan Kocaman; Hilal Özkıncı; Yusuf Kahya; Serpil Dizbay Sak; Ayten Kayı Cangır
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2022-01-28       Impact factor: 0.332

2.  Common Presentation of Uncommon Disease: Inflammatory myofibroblastic tumor of the lung, case report.

Authors:  Safwat Eldaabossi; Lotfi Maghmoul; Elsaid Lotfy; Ahmad Antar; Yasser Elghoneimy; Hameed Aljawad; Ayman Ghoneim
Journal:  Respir Med Case Rep       Date:  2022-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.